Literature DB >> 16314105

Diversity-oriented chemical modification of heparin: Identification of charge-reduced N-acyl heparin derivatives having increased selectivity for heparin-binding proteins.

Liusheng Huang1, Robert J Kerns.   

Abstract

The diversity-oriented chemical modification of heparin is shown to afford charge-reduced heparin derivatives that possess increased selectivity for binding heparin-binding proteins. Variable N-desulfonation of heparin was employed to afford heparin fractions possessing varied levels of free amine. These N-desulfonated heparin fractions were selectively N-acylated with structurally diverse carboxylic acids using a parallel synthesis protocol to generate a library of 133 heparin-derived structures. Screening library members to compare affinity for heparin-binding proteins revealed unique heparin-derived structures possessing increased affinity and selectivity for individual heparin-binding proteins. Moreover, N-sulfo groups in heparin previously shown to be required for heparin to bind specific proteins have been replaced with structurally diverse non-anionic moieties to afford identification of charge-reduced heparin derivatives that bind these proteins with equivalent or increased affinity compared to unmodified heparin. The methods described here outline a process that we feel will be applicable to the systematic chemical modification of natural polyanionic polysaccharides and the preparation of synthetic oligosaccharides to identify charge-reduced high affinity ligands for heparin-binding proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314105     DOI: 10.1016/j.bmc.2005.11.013

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Synthesis, separation, and characterization of amphiphilic sulfated oligosaccharides enabled by reversed-phase ion pairing LC and LC-MS methods.

Authors:  Amanda M Fenner; Robert J Kerns
Journal:  Carbohydr Res       Date:  2011-09-24       Impact factor: 2.104

2.  N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3.

Authors:  Ioana Craciun; Amanda M Fenner; Robert J Kerns
Journal:  Glycobiology       Date:  2016-02-05       Impact factor: 4.313

3.  Selective inhibition of bacterial and human topoisomerases by N-arylacyl O-sulfonated aminoglycoside derivatives.

Authors:  Amanda M Fenner; Lisa M Oppegard; Hiroshi Hiasa; Robert J Kerns
Journal:  ACS Med Chem Lett       Date:  2013-05-09       Impact factor: 4.345

Review 4.  Heparin: an intervenor in cell communication.

Authors:  Xianxiang Xu; Yue Dai
Journal:  J Cell Mol Med       Date:  2009-07-31       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.